Evidence map›Paper›PMID 17571166›Full record

ArticleThe Journal of clinical investigation2007

FKBP52 deficiency-conferred uterine progesterone resistance is genetic background and pregnancy stage specific.

Susanne Tranguch, Haibin Wang, Takiko Daikoku, Huirong Xie, David F Smith, Sudhansu K Dey

Abstract read
In one paragraph

Article in The Journal of clinical investigation, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed.

  1. SAV1 in Cooperation With FKBP52 Participates in Implantation.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Transgenic mice applications in the study of endometriosis pathogenesis.Frontiers in cell and developmental biology · 2024
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. P38α MAPK is a gatekeeper of uterine progesterone responsiveness at peri-implantation via Ube3c-mediated PGR degradation.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  14. Uterine Deletion ofInternational journal of molecular sciences · 2022
    Article
  15. Review
  16. [miR-483-5p aggravates cisplatin-induced premature ovarian insufficiency in rats by targeting FKBP4].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Sex-Steroid Signaling in Lung Diseases and Inflammation.Advances in experimental medicine and biology · 2021
    Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Susanne TranguchDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, TN 37232-2678, USA.
Haibin Wang
Takiko Daikoku
Huirong Xie
David F Smith
Sudhansu K Dey

Funding

PROJECT 3 - Steroid-Metabolic Interactions In the Control of GnRH NeuronsU54HD028934 · NICHD · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI MCCARTNEY, CHRISTOPHER ROLLAND · 1998 to 2013
$16.5M
MULTIDISCIPLINARY TRAINING IN MOLECULAR ENDOCRINOLOGYT32DK007563 · NIDDK · VANDERBILT UNIVERSITY · PI Richard M O'Brien · 1988 to 2026
$15.9M
UTERINE VASCULAR CHANGES &ANGIOGENESIS DURING IMPLANTATIONU54HD033994 · NICHD · UNIVERSITY OF KANSAS MEDICAL CENTER · PI TERRANOVA, PAUL FRANK · 2001 to 2005
$5.6M
ASPECTS OF BLASTOCYST IMPLANTATIONR37HD012304 · NICHD · VANDERBILT UNIVERSITY · PI DEY, SUDHANSU K · 1999 to 2010
$2.9M
INTERACTION OF PROGESTERONE RECEPTOR WITH FKBPSR01DK048218 · NIDDK · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI SMITH, DAVID F. · 1994 to 2006
$1.5M
TRANSCRIPTIONAL REGULATION OF GONADOTROPIN BETA SUBUNITS DURING DEVELOPMENTP30HD033994 · NICHD · UNIVERSITY OF KANSAS MEDICAL CENTER · PI HUNT, JOAN SHERAR · 1996 to 2000
$445k
Molecular signaling in implantationR03HD050315 · NICHD · VANDERBILT UNIVERSITY · PI WANG, HAIBIN · 2006 to 2007
$149k
Cannabinoid-Immunophilin Signaling During PregnancyF31DA021062 · NIDA · VANDERBILT UNIVERSITY · PI TRANGUCH, SUSANNE L · 2006 to 2006
$31k
ROLE OF HISTAMINE IN EARLY PREGNANCYR01HD012304 · NICHD · UNIVERSITY OF KANSAS MEDICAL CENTER · PI DEY, SUDHANSU K · 1985 to 1998
–
NICHD NIH HHS HD033994NICHD NIH HHS HD050315NICHD NIH HHS HD12304NICHD NIH HHS P30 HD033994NICHD NIH HHS R03 HD050315NICHD NIH HHS R37 HD012304NICHD NIH HHS U54 HD028934NICHD NIH HHS U54 HD033994NICHD NIH HHS U54 HD28934NIDA NIH HHS F31 DA021062NIDDK NIH HHS DK48218NIDDK NIH HHS R01 DK048218NIDDK NIH HHS T32 DK007563NIDDK NIH HHS T32 DK07563
6 · The paper itself

Abstract

Immunophilin FKBP52 serves as a cochaperone to govern normal progesterone (P(4)) receptor (PR) function. Using Fkbp52(-/-) mice, we show intriguing aspects of uterine P(4)/PR signaling during pregnancy. Implantation failure is the major phenotype found in these null females, which is conserved on both C57BL6/129 and CD1 backgrounds. However, P(4) supplementation rescued implantation and subsequent decidualization in CD1, but not C57BL6/129, null females. Surprisingly, experimentally induced decidualization in the absence of blastocysts failed in Fkbp52(-/-) mice on either background even with P(4) supplementation, suggesting that embryonic signals complement uterine signaling for this event. Another interesting finding was that while P(4) at higher than normal pregnancy levels conferred PR signaling sufficient for implantation in CD1 null females, these levels were inefficient in maintaining pregnancy to full term. However, elevating P(4) levels further restored PR signaling to a level optimal for successful term pregnancy with normal litter size. Collectively, the results show that the indispensability of FKBP52 in uterine P(4)/PR signaling is a function of genetic disparity and is pregnancy stage specific. Since there is evidence for a correlation between P(4) supplementation and reduced risks of P(4)-resistant recurrent miscarriages and remission of endometriosis, these findings have clinical implications for genetically diverse populations of women.

Indexed as

Drug ResistanceAnimalsBlastocystEmbryo TransferFemaleMiceMice, KnockoutPregnancyProgesteroneReceptors, ProgesteroneSignal TransductionTacrolimus Binding ProteinsUterusProgesteroneReceptors, Progesteronetacrolimus binding protein 4Tacrolimus Binding Proteins

Identifiers

PMID17571166
PMCPMC1888571

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.